BackZealand Pharma A/S Overview

Zealand Pharma A/S Profit Margin

Zealand Pharma A/S (ZLDPF) has a profit margin of 67.14%, above the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-1350.00%
↓ 65.54% YoY

As of Sep 2026

Annual Profit Margin (TTM)

67.14%
↓ 6.05% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Zealand Pharma A/S (ZLDPF) FAQ

Zealand Pharma A/S posts a profit margin of 67.14% as of September 2026. That compares with 71.47% in the prior-year period — down 6.1% year over year. That is above the Healthcare sector average of 17.63%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Zealand Pharma A/S's profit margin was 71.47%. The latest reading is 67.14% — a 6.1% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 17.63% is typical. Zealand Pharma A/S's 67.14% is higher that level. That is roughly 280.9% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Zealand Pharma A/S's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 67.14% as of September 2026; use YoY and peer views to separate noise from signal.

Context for ZLDPF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.63%), and (3) consistency with growth and profitability. This page covers the first two; Zealand Pharma A/S's other metric pages and overview cover the third.